Copay assistance fund status, eligibility, and covered drugs — for patient access and billing teams.
Maximum award No cap on assistance (unless otherwise specified) · Income Income-based eligibility; threshold not published · Copayments, coinsurance, deductibles, health insurance premiums, incidental medical expenses
Published terms from the foundation. Per-patient eligibility and amounts are confirmed at application.
C82.0 C82.00 C82.01 C82.02 C82.03 C82.04 C82.05 C82.06 C82.07 C82.08 C82.09 C82.1 C82.10 C82.9 C82.90 C83.0 C83.3 C83.30 C83.31 C83.32 C83.33 C83.34 C83.35 C83.36 C83.37 C83.38 C83.39 C83.5 C83.8 C83.9 C83.90 C85.1 C85.9 C85.90 C91.1 C91.10 C91.11 L10.0 M05.79 M06.9 M31.30 M31.31 M31.7 M32.14Drugs whose J-codes this fund matches. Each links to its billing & coding reference.
Also matches J-codes not yet in our drug library: J9075 J9268 J9311 J9349 Q5123
Run a Medicare estimate for a covered drug in about a minute. The fund's award caps against the patient share CareCost calculates.
As of June 3, 2026, the The Assistance Fund B-Cell Lymphoma fund is OPEN and accepting applications. Verify at time of service: 833-844-5182.
No cap on assistance (unless otherwise specified). Copayments, coinsurance, deductibles, health insurance premiums, incidental medical expenses
Household income must be Income-based eligibility; threshold not published. U.S. resident.
Accepted: commercial, medicare, medicaid.